Up next

Autoplay

TWILIGHT-Stent: Ticagrelor Monotherapy According to Stent Type | Dr George Dangas

0 Views • 08/26/25
Share
Side Effects
Side Effects
Subscribers
0

Watch the full video on Radcliffe Cardiology: https://www.radcliffecardiolog....y.com/video-index/tw

Dr George Dangas (Mount Sinai Hospital, New York, NY, US) discusses the results of the TWILIGHT-Stent trial, presented at ESC 2021. This study examined the incidence of ischemic and bleeding events in patients treated with contemporary drug-eluting stents over 3-15 months. This trial also examined ticagrelor monotherapy vs ticagrelor with aspirin.

Questions:
1. What were the main aims of TWILIGHT-Stent?
2. What are your key findings?
3. What are the next steps?

Filmed remotely from New York, NY, 2021.

Interviewer: Jordan Rance

Radcliffe Cardiology is a dynamic, digitally-focused producer & publisher of Cardiovascular, Renal and Metabolic (CVRM) content for physicians worldwide. We aim to assist in the continuous education of physicians within the cardiology fraternity, generating a range of clinical content through collaboration with leading cardiologists from around the globe.

Show more
0 Comments sort Sort By

Up next

Autoplay